Metformin and HER2-positive breast cancer: Mechanisms and therapeutic implications-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Metformin and HER2-positive breast cancer: Mechanisms and therapeutic implications

Published:2023-06 Issue: Volume:162 Page:114676
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Bashraheel Sara S,Kheraldine Hadeel,Khalaf Sarah,Moustafa Ala-Eddin Al

Funder

Qatar National Library

Qatar University

Qatar National Research Fund

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference151 articles.

1. Molecular classification of breast carcinoma: from traditional, old-fashioned way to a new age, and a new way;Eliyatkin;J. Breast Health,2015

2. Risk factors and preventions of breast cancer;Sun;Int J. Biol. Sci.,2017

3. Diabetes as a risk factor for breast cancer;Eketunde;Cureus,2020

4. Type 2 diabetes and breast cancer: the interplay between impaired glucose metabolism and oxidant stress;Ferroni;Oxid. Med Cell Longev.,2015

5. Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study;Michels;Diabetes Care,2003

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of metformin on incidence, recurrence, and mortality in prostate cancer patients: integrating evidence from real-world studies;Prostate Cancer and Prostatic Diseases;2024-07-16

2. Metformin: From Diabetes to Cancer—Unveiling Molecular Mechanisms and Therapeutic Strategies;Biology;2024-04-27

3. Ianus Bifrons: The Two Faces of Metformin;Cancers;2024-03-26

4. Emerging insights into mechanisms of trastuzumab resistance in HER2-positive cancers;International Immunopharmacology;2023-09

5. Metformin as a promising target for DPP4 expression: computational modeling and experimental validation;Medical Oncology;2023-08-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3